XML 43 R29.htm IDEA: XBRL DOCUMENT v3.20.2
Segment Reporting (Tables)
6 Months Ended
Jun. 30, 2020
Segment Reporting  
Schedule of financial information by reporting segment

Three Months Ended

Six Months Ended

June 30, 

June 30, 

2020

2019

2020

2019

(in thousands)

Net revenues:

    

    

    

    

    

    

    

    

 

Finished pharmaceutical products

$

80,935

$

73,735

$

162,233

$

148,274

API

 

4,871

 

5,312

 

8,261

10,563

Total net revenues

 

85,806

 

79,047

 

170,494

 

158,837

Gross profit:

Finished pharmaceutical products

 

35,437

 

34,540

 

74,247

 

66,852

API

 

(2,260)

 

(2,153)

 

(4,247)

(3,562)

Total gross profit

 

33,177

 

32,387

 

70,000

 

63,290

Operating expenses

 

36,099

 

31,414

 

65,442

 

65,489

(Loss) income from operations

 

(2,922)

 

973

 

4,558

 

(2,199)

Non-operating expense

 

1,418

 

60,120

 

(257)

 

59,659

(Loss) income before income taxes

$

(1,504)

$

61,093

$

4,301

$

57,460

Schedule of net revenues in the finished pharmaceutical products segment

Three Months Ended

Six Months Ended

June 30, 

June 30, 

2020

2019

2020

2019

(in thousands)

Finished pharmaceutical products net revenues:

    

    

    

    

    

    

    

 

Primatene® Mist

$

12,468

$

2,512

$

25,345

$

5,409

Phytonadione

 

10,689

 

12,441

 

21,718

 

22,561

Enoxaparin

10,218

9,838

19,386

24,322

Lidocaine

7,608

10,082

18,265

22,061

Naloxone

8,723

7,833

17,598

15,197

Epinephrine

6,957

3,139

10,947

5,818

Other finished pharmaceutical products

 

24,272

 

27,890

 

48,974

 

52,906

Total finished pharmaceutical products net revenues

$

80,935

$

73,735

$

162,233

$

148,274

Schedule of depreciation and amortization expense by reporting segment

Three Months Ended

Six Months Ended

June 30, 

June 30, 

2020

2019

2020

2019

(in thousands)

Depreciation and amortization expense

    

    

    

    

    

    

    

    

 

Finished pharmaceutical products

$

1,453

$

1,371

$

2,917

$

2,721

API

 

575

 

290

 

1,157

575

Total depreciation and amortization expense

$

2,028

$

1,661

$

4,074

$

3,296

Schedule of net revenues and carrying values of long-lived assets by geographic region

Net Revenue

Long-Lived Assets

 

Three Months Ended

Six Months Ended

 

June 30, 

June 30, 

June 30, 

December 31, 

2020

2019

2020

2019

2020

2019

 

(in thousands)

 

United States

    

$

81,898

    

$

74,781

    

$

162,963

    

$

151,238

    

$

106,301

    

$

108,399

China

 

295

 

984

 

523

 

984

 

81,951

 

79,846

France

 

3,613

 

3,282

 

7,008

6,615

 

49,984

 

45,611

Total

$

85,806

$

79,047

$

170,494

$

158,837

$

238,236

$

233,856